I'm a partner in  <a href="http://www.gzdixin.com/43/187.html">canada med store
</a>  Traditional antibody-based therapies only recognize changes on the surface of cells. Laurent Jespers, head of innovation at GSK's biopharmaceuticals unit, said ImmTACs offered "a tremendous opportunity" in treating cancer.